GCP
IDXX icon

Gill Capital Partners’s Idexx Laboratories IDXX Stock Holding History

Gill Capital Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.69K Hold
7
– – ﹤0.01% 535
2026
Q1 		$3.93K Buy
+7
New +$4.49K ﹤0.01% 510

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Gill Capital Partners's IDXX Position: Q2 2026 in Review

Gill Capital Partners held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 7 shares worth $3.69K. The position accounts for ﹤0.01% of the portfolio, ranked #535.

Gill Capital Partners first reported a position in IDXX in Q1 2026 and has held it in 2 quarters since. The position peaked at $3.93K in Q1 2026. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Gill Capital Partners held 7 shares of Idexx Laboratories worth $3.69K as of Q2 2026.
  • Gill Capital Partners left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up ﹤0.01% of Gill Capital Partners's portfolio in Q2 2026, its #535 holding.
  • Gill Capital Partners first reported a position in Idexx Laboratories in Q1 2026 and has held it in 2 quarters since.
  • Gill Capital Partners's Idexx Laboratories position peaked at $3.93K in Q1 2026.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Gill Capital Partners's 13F filing for Q2 2026, filed 20 Aug 2026.